SwRI, UTSA to team on $18M vaccine development project

Southwest Research Institute will share in an $18 million contract from the U.S. Department of Defense to develop a vaccine that can be used to protect humans from tularemia, a potential biothreat also known as rabbit fever. SwRI will share the contract with the University of Texas at San Antonio and Lovelace Respiratory Research Institute, which is based in New Mexico. SwRI's pharmaceutical testing laboratories will formulate UTSA’s modified bacterium for human clinical trials using intradermal…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news